Novartis says it buried studies

Share this article:

Novartis says it failed to reveal 10,000 reports of side effects. The Wall Street Journal reports that the drugmaker says it has identified at least 10,000 cases which may never have been reported and which span a variety of drugs, including Gleevec, Tasigna, Exelon and Xolair.

Novartis tells the WSJ it has passed along this information to the Japanese Ministry of Health Labor and Welfare and the FDA, among others.

Novartis has been working against a series of bad PR moments, and this latest one compounds a problem highlighted two months ago, when Novartis said it had shredded or deleted some safety reports surrounding leukemia medications Gleevec and Tasigna.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.